Correlation Between Cue Biopharma and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Verrica Pharmaceuticals, you can compare the effects of market volatilities on Cue Biopharma and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Verrica Pharmaceuticals.
Diversification Opportunities for Cue Biopharma and Verrica Pharmaceuticals
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cue and Verrica is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cue Biopharma and Verrica Pharmaceuticals
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Verrica Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cue Biopharma is 1.63 times less risky than Verrica Pharmaceuticals. The stock trades about -0.1 of its potential returns per unit of risk. The Verrica Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 153.00 in Verrica Pharmaceuticals on September 2, 2024 and sell it today you would lose (25.00) from holding Verrica Pharmaceuticals or give up 16.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Verrica Pharmaceuticals
Performance |
| Timeline |
| Cue Biopharma |
| Verrica Pharmaceuticals |
Cue Biopharma and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Verrica Pharmaceuticals
The main advantage of trading using opposite Cue Biopharma and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |